呼吸困难对接受心脏负荷试验患者的预后意义

来源 :世界核心医学期刊文摘(心脏病学分册) | 被引量 : 0次 | 上传用户:along0429
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND: Although dyspnea is a common symptom, there has been only limited investigation of its prognostic significance among patients referred for cardiac evaluation. METHODS: We studied 17,991 patients undergoing myocardial-perfusion single-photon-emission computed tomography during stress and at rest. Patients were divided into five categories on the basis of symptoms at presentation(none, nonanginal chest pain, atypical angina, typical angina, and dyspnea). Multivariable analysis was used to assess the incremental prognostic value of symptom categories in predicting the risk of death from cardiac causes and from any cause. In addition, the prognosis associated with various symptoms at presentation was compared in subgroups selected on the basis of propensity analysis.RESULTS: After a mean(±SD)follow-up of 2.7±1.7 years, the rate of death from cardiac causes and from any cause was significantly higher among patients with dyspnea(both those previously known to have coronary artery disease and those with no known history of coronary artery disease)than among patients with other or no symptoms at presentation. Among patients with no known history of coronary artery disease, those with dyspnea had four times the risk of sudden death from cardiac causes of asymptomatic patients and more than twice the risk of patients with typical angina. Dyspnea was associated with a significant increase in the risk of death among each clinically relevant subgroup and remained an independent predictor of the risk of death from cardiac causes(P< 0.001)and from any cause(P< 0.001)after adjustment for other significant factors by multivariable and propensity analysis. CONCLUSIONS: In a large series of patients, self-reported dyspnea identified a subgroup of otherwise asymptomatic patients at increased risk for death from cardiac causes and from any cause. Our results suggest that an assessment of dyspnea should be incorporated into the clinical evaluation of patients referred for cardiac stress testing. BACKGROUND: Although dyspnea is a common symptom, there has been only only limited investigation of its prognostic significance among patients referred for cardiac evaluation. METHODS: We studied 17,991 patients undergoing myocardial perfusion single-photon-emission computed tomography during stress and at rest. Patients were divided into five categories on the basis of symptoms at presentation (none, nonanginal chest pain, atypical angina, typical angina, and dyspnea). Multivariable analysis was used to assess the incremental prognostic value of symptom categories in predicting the risk of death from cardiac causes and from any cause. In addition, the prognosis associated with various symptoms at presentation was compared in subgroups selected on the basis of propensity analysis .RESULTS: After a mean (± SD) follow-up of 2.7 ± 1.7 years, the rate of death from cardiac causes and from any cause was significantly higher among patients with dyspnea (both those previously known to have coronary arte ry disease and those with no known history of coronary artery disease) than among patients with other or no symptoms at presentation. Among patients with no known history of coronary artery disease, those with dyspnea had four times the risk of sudden death from cardiac causes of asymptomatic patients and more than twice the risk of patients with typical angina. Dyspnea was associated with a significant increase in the risk of death among each clinically relevant subgroup and remained an independent predictor of the risk of death from cardiac causes (P <0.001) and from any cause (P <0.001) after adjustment for other significant factors by multivariable and propensity analysis. CONCLUSIONS: In a large series of patients, self-reported dyspnea identified a subgroup of otherwise asymptomatic patients at increased risk for death from cardiac causes and from any cause. Our results suggest that an assessment of dyspnea should be incorporated into the clinical evaluation of patients referred to c ardiac stress testing.
其他文献
一项高血压患者的研究结果表明,与常用的基于β阻滞剂的抗高血压疗法相比,基于钙通道阻滞剂氨氯地平(amlodipine)的高血压疗法已被证实可使高血压人群新发糖尿病的几率减少3
位于柳州市鹿寨县的广西七色珠光材料股份有限公司是一家在全国中小企业股份转让系统挂牌上市的国家级高新技术企业。现有职工427人,拥有实力雄厚的珠光材料研发中心和研发团
上海耀华皮尔金顿玻璃股份有限公司是一家中英合资的大型玻璃及玻璃深加工企业。企业党组织开展思想政治工作,主要在建材集团党委领导和合资企业的框架模式下进行。思想政治
目的:了解农四师农牧团场充血性心力衰竭住院患者病因、药物治疗、转归、死亡等10年间变化方法:将入院986例CHF患者分成1995—1998段组(A组),2002年—2005年级组(B组)分别对
陕西神木28000Nm3/h空分设备是2003年川空集团承接的煤化工用成套空分设备,属中压内压缩流程,难度大,要求高,与之配套的增压透平膨胀机由川空低机公司研制。 Shaanxi Shenmu
目的:掌握贵州省2007年度燃煤型病区地氟病病情现状、消长和发展趋势以及降氟措施落实进度及降氟设施使用管理情况,为制定燃煤污染型防治策略提供科学依据。方法:按照全国地
企业薪酬结构在实现企业自身的战略目标和竞争优势过程中具有十分关键的作用.可以认为,薪酬制度的设计和实施是整个企业人力资源管理过程中最复杂的工作。上海石化在完善现
剖析了高温超导材料YBa2Cu3O7-X(简称YBCO)在高温的氧化还原反应过程和伴随发生的吸氧、放氧过程以及它们对空气分离和气体纯化的贡献。还给出中试实验结果与国外高纯氮气标
目的建立同时测定沉积物中15种多环芳烃(PAHs)污染物的凝胶渗透色谱-高效液相色谱分析方法。方法样品中的多环芳烃通过环己烷-乙酸乙酯(1∶1,V/V)提取,凝胶渗透色谱净化,液相
提出了降低能耗的甲醇驰放气提氢新工艺,并分析了新工艺的实施方案和应用特点。说明甲醇驰放气提氢工段工艺的改进不仅大有必要,也是完全可行的。 Proposed a new technolog